Self-selected or Predetermined Internet-based Treatment for Generalized Anxiety Disorder With Different Types of Support

Generalized Anxiety Disorder Clinical Trial

Official title:

Self-selected or Predetermined Internet-based Cognitive Behavior Therapy for Generalized Anxiety Disorder With Weekly Support or Support on Demand: A Factorial Treatment Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03807193
• Other study ID #: worry factorial
• Status: Completed
• Phase: N/A
• Start date: February 12, 2019
• Est. completion date: December 10, 2020

Study information

• Verified date: February 2021
• Source: Linkoeping University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates two types of internet-based treatments for generalized anxiety disorder and two types of support. The treatments are a predetermined program for generalized anxiety disorder and a self-selected treatment. The different types of support are either a weekly contact trough a secure message system or support on demand.

Description:

Generalized anxiety disorder (GAD) is characterize by and excessive and uncontrollable worry that is present more days than not. The disorder is best described as a chronic condition with periods with more or less symptoms. The disorder is highly disabling with low quality of life for the individual and is associated with and high costs for society. Previous studies on internet-based cognitive behavior therapy for GAD has shown positive effects but there are still room for improvement.

The aim of this study is to evaluate two different internet-based treatments as well as two types of support through the use of a factorial design. The participants will be recruited trough advertising. After registration on the study's website the potential participants will be asked to answer screening questionnaires and demographic data for an initial screening. Those meeting inclusion criteria will be contacted for a diagnostic interview based Mini-International Neuropsychiatric Interview (M.I.N.I.). If meeting the study's inclusion criteria and not the exclusion criteria the participant will be included in the study and randomized to one of the four arms. The four arms are: Predetermined treatment program with weekly support, Predetermined treatment program with support on demand, Self-selected treatment with weekly support, Self-selected treatment with support on demand.

The predetermined treatment program is designed for treatment of worry and generalized anxiety disorder. It is based on newer forms of cognitive behavior therapy and includes mindfulness and acceptance. In the self-selected treatment the participants will select treatment interventions with the help of a manual and encouraged to choose interventions that they feel address their specific problems. The interventions that will be available are all based on standard cognitive behavior therapy techniques. The weekly support will be scheduled and delivered by clinical psychology students under supervision. This contact will be based on reports from the participants on the weeks work with the program and exercises. The support on demand will be also be delivered by clinical psychology students under supervision. This support takes place if and when the participant ask for support. Treatment will be 8 weeks long and both treatments will be delivered through the same platform. Contact with the participants will be trough written messages on a secure platform.

After the eight weeks of treatment the participants will be asked to answer the same measures as before the treatment as well as questions regarding how they experience the treatment. Follow up data will be collected at later points.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 85
• Est. completion date: December 10, 2020
• Est. primary completion date: December 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• At least 18 years old

• fulfilling criteria for generalized anxiety syndrome

• 45 points or more on PSWQ

• Able to read and write in Swedish

• Have daily access to a computer and internet

Exclusion Criteria:

• Alcohol or substance abuse

• Acute suicidal

• Ongoing psychological treatment

• Ongoing medication for anxiety or depression that is planned to be adjusted during the time of the treatment given in the study

• Complex psychiatric illness that highly disabling

Related Conditions & MeSH terms

• Anxiety Disorders
• Generalized Anxiety Disorder

Intervention

Behavioral:
• Self-selected treatment
The participants will select their own treatment material with the help of a written manual. The interventions possible to choose are all interventions used in standard cognitive behavior therapy for anxiety and depression.
• Predetermined treatment
The participants will be given a treatment program designed to address worry and generalized anxiety disorder. The program are based on newer forms of cognitive behavior therapy and include mindfulness and acceptance.
• Weekly support
The participants will have scheduled weekly support, once a week, during the treatment. The support till be delivered by students in clinical psychology.
• Support on demand
The participants will have support if and when they ask for it by themselves. If asked for the support will be delivered by students in clinical psychology.

Locations

Country	Name	City	State
Sweden	Linköpings universitet	Linköping	Östergötland

Sponsors (1)

Lead Sponsor	Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in Penn State Worry Questionnaire (PSWQ)	Measures symptoms severity of worry. 16 items, with score range 16-80. Higher score indicates worse symptoms	Baseline, 8 weeks, 24 months and 36 months after treatment
Secondary	Change from baseline in Generalized Anxiety Disorder Questionnaire IV (GAD-Q-IV)	Designed to capture the criteria for generalized anxiety disorder according to diagnostic and statistical manual of mental disorders (DSM), 9 items with score range 0-12. Higher scores indicate greater symptom severity	Baseline, 8 weeks, 24 months and 36 months after treatment
Secondary	Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)	Screening measure for worry and anxiety symptoms. 7 items, score range 0-21. Higher scores indicate greater symptom severity	baseline and weekly during 8 weeks treatment. 24 months and 36 months after treatment
Secondary	Change from baseline in Beck Anxiety Inventory (BAI)	Measure of anxiety symptoms. 21 items with score range 0-63. Higher scores indicate greater symptom severity	Baseline, 8 weeks, 24 months and 36 months after treatment
Secondary	Change from baseline in Patient Health Questionnaire (PHQ-9)	Screening measure for depressive symptoms. 9 items with score range 0-27. Higher scores indicate greater symptom severity	baseline and weekly during 8 weeks treatment. 24 months and 36 months after treatment
Secondary	Beck Depression II Inventory (BDI-II)	Measure of severity of depressive symptoms. 21 items with score range 0-63. Higher scores indicate greater symptom severity	Baseline, 8 weeks, 24 months and 36 months after treatment
Secondary	Acceptance and Action Questionnaire II (AAQ-II)	Measure of psychological flexibility. 7 items with score range 7-49 with higher scores indicate lower psychological flexibility	Baseline, 8 weeks, 24 months and 36 months after treatment
Secondary	Brunnsviken Brief Quality of life scale (BBQ)	12 items, measures the quality of life. 12 items with score 0-96. Higher score indicate higher quality of life	Baseline, 8 weeks, 24 months and 36 months after treatment
Secondary	General self-efficacy scale	Measure of percieved self-efficay. 10 items rated on a four-point Likert scale. Score range 10-40 with a higher score indicating a higher percieved self-efficacy.	Baseline, 8 weeks, 24 months and 36 months after treatment